Cargando…

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a recently identified and potentially useful plasma biomarker for cardiovascular diseases. However, its role in peripheral arterial disease (PAD) remains unclear. The objective of this study was to assess the independent association of Lp-PLA(...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, SHUAI-BING, YANG, FAN, JING, LI, MA, JUAN, JIA, YA-DAN, DONG, SHAO-YING, ZHENG, WEI-FENG, ZHAO, LUO-SHA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671896/ https://www.ncbi.nlm.nih.gov/pubmed/23737897 http://dx.doi.org/10.3892/etm.2013.1005

Ejemplares similares

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease
por: Cen, Jin-Ming, et al.
Publicado: (2015)

The correlation between lipoprotein associated phospholipase A(2) and central overweight status
por: Chen, Yi-Hsuan, et al.
Publicado: (2021)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

Association Between Plasma Lipoprotein-Associated Phospholipase A2 and Plaque Vulnerability in TIA Patients With Unilateral Middle Cerebral Artery Stenosis
por: Qin, Yiren, et al.
Publicado: (2020)

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
por: Ding, Yao-dong, et al.
Publicado: (2020)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients
por: Ling, Yang, et al.
Publicado: (2020)

Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A(2) and secretory phospholipase A(2) in patients with newly diagnosed type 2 diabetes
por: Lin, Xiu-hong, et al.
Publicado: (2016)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

Plasma Lipoprotein-Associated Phospholipase A2 Affects Cognitive Impairment in Patients with Cerebral Microbleeds
por: Liu, Lu, et al.
Publicado: (2023)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

Carotid artery color Doppler ultrasonography and plasma levels of lipoprotein-associated phospholipase A2 and cystatin C in arteriosclerotic cerebral infarction
por: Huang, Lei, et al.
Publicado: (2019)

Negative correlation between early recovery and lipoprotein-associated phospholipase A2 levels after intravenous thrombolysis
por: Li, Yanzheng, et al.
Publicado: (2022)

Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
por: Zhang, Xiaojiu, et al.
Publicado: (2022)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
por: Mourouzis, Konstantinos, et al.
Publicado: (2021)

The Relationship Between Lipoprotein-Associated Phospholipase-A2 and Coronary Artery Aneurysm in Children With Kawasaki Disease
por: Cheng, Zhenli, et al.
Publicado: (2022)

Plasma Lipoprotein-Associated Phospholipase A(2) Levels Correlated with the Cardio-Ankle Vascular Index in Long-Term Type 2 Diabetes Mellitus Patients
por: Kotani, Kazuhiko
Publicado: (2016)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Increased Lipoprotein-associated phospholipase A2 activity portends an increased risk of resistant hypertension
por: Li, Zhiming, et al.
Publicado: (2016)

DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A(2) in human vulnerable atherosclerotic plaque
por: Li, Jingjin, et al.
Publicado: (2021)

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
por: Dhamoon, Mandip S., et al.
Publicado: (2019)

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
por: Zhang, Juan, et al.
Publicado: (2016)

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults
por: Lee, Keane K, et al.
Publicado: (2011)

Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
por: Feng, Li-Min, et al.
Publicado: (2014)

A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass
por: Qi, Yue, et al.
Publicado: (2016)

Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
por: Maiolino, Giuseppe, et al.
Publicado: (2012)

Clinical Utility of the Serum Level of Lipoprotein-Related Phospholipase A2 in Acute Ischemic Stroke With Cerebral Artery Stenosis
por: Cao, Jing, et al.
Publicado: (2021)

Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein‐Associated Phospholipase A(2)
por: Fenning, Robert S., et al.
Publicado: (2015)

Endothelial Dysfunction in Children With Obstructive Sleep Apnea Is Associated With Elevated Lipoprotein‐Associated Phospholipase A2 Plasma Activity Levels
por: Kheirandish‐Gozal, Leila, et al.
Publicado: (2017)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Taiwanese Female Vegetarians Have Lower Lipoprotein-Associated Phospholipase A2 Compared with Omnivores
por: Chen, Chih-Wei, et al.
Publicado: (2011)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Lipoprotein-associated phospholipase A(2): A paradigm for allosteric regulation by membranes
por: Mouchlis, Varnavas D., et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_slpacbm80s4pelvfsd5pfrscra